These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

111 related items for PubMed ID: 225097

  • 41. Angiotensin in the nucleus tractus solitarii contributes to neurogenic hypertension caused by chronic nitric oxide synthase inhibition.
    Eshima K, Hirooka Y, Shigematsu H, Matsuo I, Koike G, Sakai K, Takeshita A.
    Hypertension; 2000 Aug; 36(2):259-63. PubMed ID: 10948087
    [Abstract] [Full Text] [Related]

  • 42. Pressor responsiveness to angiotensin in renovascular and steroid hypertension.
    Marks ES, Thurston H, Bing RF, Swales JD.
    Clin Sci (Lond); 1979 Dec; 57 Suppl 5():47s-50s. PubMed ID: 396091
    [Abstract] [Full Text] [Related]

  • 43. Inhibition of angiotensin conversion and prevention of renal hypertension.
    Miller ED, Samuels AI, Haber E, Barger AC.
    Am J Physiol; 1975 Feb; 228(2):448-53. PubMed ID: 235218
    [Abstract] [Full Text] [Related]

  • 44. Pharmacological profile of valsartan, a non-peptide angiotensin II type 1 receptor antagonist. 1st communication: antihypertensive effects of valsartan in hypertensive models.
    Yamamoto S, Hayashi N, Kometani M, Nakao K, Inukai T.
    Arzneimittelforschung; 1997 May; 47(5):604-12. PubMed ID: 9205773
    [Abstract] [Full Text] [Related]

  • 45. Reversible renovascular hypertension and renal arterial pressure.
    Tagawa H, Gutmann FD, Haber E, Miller ED, Samuels AI, Barger AC.
    Proc Soc Exp Biol Med; 1974 Sep; 146(4):975-82. PubMed ID: 4424032
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. Reversal of microvascular rarefaction and reduced renal mass hypertension.
    Rieder MJ, Roman RJ, Greene AS.
    Hypertension; 1997 Jul; 30(1 Pt 1):120-7. PubMed ID: 9231831
    [Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. Is the peripheral sympatho-adrenal nervous system necessary for renal hypertension?
    Douglas JR, Johnson EM, Heist JF, Marshall GR, Needleman P.
    J Pharmacol Exp Ther; 1976 Jan; 196(1):35-43. PubMed ID: 1246014
    [Abstract] [Full Text] [Related]

  • 53. Different effects of captopril on blood pressure in the acute and chronic two-kidney Goldblatt hypertensive dogs.
    Ohara N, Ono H, Hashimoto K.
    Jpn Circ J; 1982 Jul; 46(7):706-14. PubMed ID: 7047789
    [Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58. Study of renovascular hypertension in rats: I. The role of the contralateral, non-clipped kidney in two-kidney, one-clip hypertension in rats.
    Matsushita K.
    Tokai J Exp Clin Med; 1984 Oct; 9(4):253-8. PubMed ID: 6537038
    [Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60. Effect of the partial constriction of portal vein on renal hypertension in the rat.
    Sonkodi S, Perényi L, Zoltán OT.
    Angiologica; 1971 Oct; 8(2):77-82. PubMed ID: 4330481
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.